InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,471.56
(
-0.03%
)
US TECH 100
19,267.60
(
0.05%
)
Dow Jones
39,152.60
(
0.05%
)
Brent Oil
84.43
(
-0.68%
)
Bitcoin
63,690.01
(
-1.74%
)
Post# of 425869
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Atom0aks

Send PM Follow Ignore
Followers 4
Posts 372
Boards Moderated 0
Alias Born 08/13/2019

Atom0aks

Re: Mellowmood77 post# 223970

Saturday, 11/09/2019 7:18:27 PM

Saturday, November 09, 2019 7:18:27 PM

Post# of 425869

More absolute benefit in secondary, but that is logical as they are higher risk patients with more events.



I agree, which is why I think the FDA left it to the experts to decide whether the modest benefit is acceptable to expand the label for primary prevention.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News
InvestorsHub NewsWire

Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM

ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM

North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM

VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM

Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM

Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM

Start posting your company's news
Only $200 per official company press release!